Product Details
Your question will be sent to our team of local Roche Medical Information experts in your country. If your question does not relate to a specific Roche product select "I don't know".
Concerning Columvi (Glofitamab), Enspryng (satralizumab), Evrysdi (risdiplam), Lunsumio (mosunetuzumab), Phesgo (pertuzumab & trastuzumab), Piasky (crovalimab), Polivy (polatuzumab), Ronapreve (casirivimab & imdevimab), Rozlytrek (entrectinib), Vabysmo (faricimab), Xofluza (baloxavir marboxil):
▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.
If a pregnancy occurs while using Herceptin/PERJETA/Kadcyla/Phesgo or within 7 months following the last dose of Herceptin/Kadcyla/Phesgo or within 6 months following the last dose of PERJETA, please immediately report pregnancy to the local Roche Adverse Event line at +32 (0)2 525 82 99.
Additional information will be requested during a Herceptin/PERJETA//Phesgo/Kadcyla-exposed pregnancy and the first year of the infant's life. This will enable Roche to better understand the safety of Herceptin/PERJETA/Kadcyla/Phesgo and to provide appropriate information to health authorities, healthcare providers and patients.
Which Roche product does your question relate to?
Your question ({{form.product.label}}) ({{form.product}})
What can we help you with?
Personal Details
Are you a…
I consent to my data being processed for the purpose of responding to my inquiry and in accordance with the Roche Privacy Policy & Privacy Notice for Pharmacovigilance.
You consent, by ticking the box above, to the processing of your data for the purposes of responding to your inquiry and in accordance with the Roche Privacy Notice for Pharmacovigilance, medical information and product complaints. If you do not consent to the data processing, we will not be able to reply to your message and kindly ask you to use other channels to contact us.
F. Hoffmann-La Roche Ltd ("Roche") will keep a record of the personal data that you provide for the purpose of responding to your inquiry, to follow up on such requests, to maintain the information in the Roche medical information database for reference and to comply with our legal and regulatory recording and reporting obligations. The retention time of data is in accordance with respective laws and regulations.
By including personal data of another data subject in the form, you represent the lawfulness of processing of such personal data.
The Roche Privacy Policy provides further detailed information about your rights and how Roche processes personal data.